Compare FTRE & TOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FTRE | TOP |
|---|---|---|
| Founded | 1996 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2023 | 2021 |
| Metric | FTRE | TOP |
|---|---|---|
| Price | $18.59 | $15.82 |
| Analyst Decision | Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $23.63 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 232.8K |
| Earning Date | 10-29-2026 | 07-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.25 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,723,400,000.00 | $4,723,765.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.21 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 1.00 | ★ 41.89 |
| 52 Week Low | $8.55 | $1.85 |
| 52 Week High | $26.16 | $17.99 |
| Indicator | FTRE | TOP |
|---|---|---|
| Relative Strength Index (RSI) | 37.28 | 54.21 |
| Support Level | $16.34 | $13.96 |
| Resistance Level | $18.84 | $16.63 |
| Average True Range (ATR) | 1.34 | 1.71 |
| MACD | -0.31 | 0.36 |
| Stochastic Oscillator | 2.64 | 71.98 |
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
TOP Financial Group Ltd is operates as an online brokerage firm in Hong Kong specializing in the trading of local and overseas equities, futures, and options products. It conduct the futures and stock brokerage business through three trading platforms, Esunny for futures trading and Longbridge for stock trading, all of which were licensed from third parties and can be easily accessed through its application, or APP, software, and websites. The three platforms are designed for seamless, efficient, and secure trading platform. The company operates and manages its business as a single operating and reportable segment.